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Abstracl-Warm F. N. and BEHNKE J. M. 1992. Stimuli for acquired resistance to Heligmosonroides 
po/ygJws from intestinal tissue resident L3 and L4 larvae. Iniernaiional Journalfor Parasitology 22: 699- 
710. L3 and L4 stages of H.po/ygyrus were prevented from developing further and were probably killed 
within 24 h of treatment with ivermectin although total parasite burdens, particularly when treatment was 
given 4-6 days after infection. declined over a longer period lasting several days. Strong resistance to 
challenge infection was expressed by infected mice dosed with ivermectin during the tissue phase of larval 
development. Even immunizing infections as brief as 12-36 h (when only L3 larvae would have been present 
in the mucosa) elicited strong acquired immunity. When infections were terminated 4-6 days after infection, 
acquired resistance was 95-100%. The stronger resistance of mice exposed to both L3 and L4 stages was 
associated with the recognition of low molecular weight polypeptides in adult worm homogenate and there 
was a highly significant correiation between percentage protection and anti-L4~anti-adult worm serum IgGl 
antibodies. 
INDEX KEY WORDS: Heligmoson~oides polygyrus (Nematospiroides duhius); nematode; abbreviated 
infections; adult worm homogenate (AH) antigens; arrested development; enzyme-linked immuno- 
absorbent assay (ELISA); excretory/secretory (ES) antigens; immunomodulatory factors (IMF); 
ivermectin; mouse; strains; responder status; third-stage larvae (L3); fourth-stage larvae (L4). 
INTRODUCTION 
THE longevity of parasitic nematodes in vertebrate 
hosts is still an enigmatic phenomenon for which there 
is no conclusive explanation. Both tissue-dwelling 
species such as the filariae and intestinal species such 
as hookworms have the capacity to cause chronic in- 
fections in man and his domestic animals (reviewed by 
Behnke, 1987; Behnke. Barnard & Wakelin, in press; 
Nutman, 1989) and yet their evasive strategies, whilst 
anticipated on evolutionary considerations vis-d-vis 
the arms race (Behnke & Barnard, 1990). are hardly 
understood. The possibility that complex immuno- 
modulatory strategies have evolved to downregulate 
potentially protective host responses has been ex- 
plored extensively and a variety of mechanisms have 
been considered (Barr&a, 1984; Behnke, 1987; 
Nutman, Kumaraswami & Ottesen, 1987). 
The murine trichostrongylid Heligmosomoides 
polygyrus, a widely investigated model species in this 
context, is a natural parasite of mice but in several 
*To whom all correspondence should be addressed 
respects the parasitic life cycle of this worm is unusual. 
The L3 larvae penetrate through the mucosa and come 
to lie in the muscularis externa where development 
involving two moults takes place (Bryant, 1973). After 
7-8 days the preadults emerge into the intestinal lumen 
where they reside as adults for up to IO months post- 
infection (pi.) depending on strain of mouse 
(Ehrenford, 1954; Robinson, Wahid, Behnke & 
Gilbert, 1989). On primary exposure to the parasite, 
there is no significant loss of worms during this tissue 
phase, despite the inflammatory reaction provoked by 
the developing stages, their excretory/secretory (ES) 
products and the sheaths left behind after moulting 
(Liu, 1965; Sukhdeo, O’Grady & Hsu, 1984). 
On secondary exposure, these sites of development 
in the gut tissues become the foci of intense reactions 
resulting in prominent granulomatous lesions 
(Prowse, Mitchell, Ey & Jenkin, 1979). Larvae devel- 
oping in immune mice are usually stunted (Bartlett & 
Ball, 1974; Sitepu, Dobson & Brindley, 1985), take 
longer to complete their tissue phase of development 
(Ey. 1988a), may become arrested (Behnke & Parish, 
1979a) and are less fecund as adults (Enriquez, 
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Scarpino, Cypess & Wassom, 1988; Kerboeuf, 1985; 
Sitepu rt al., 1985). These manifestations of acquired 
resistance are all well documented. However, there is 
still controversy over the stage which finally succumbs 
to host immunity. Initially it was believed that the 
intense foci of inflammation surrounding developing 
larvae killed the parasites in situ (Bartlett & Ball, 1974; 
Chaicumpa, Prowse. Ey & Jenkin, 1977) but it was 
subsequently shown that numerous worms survived 
for a very long time in such lesions. possibly returning 
to the gut lumen to be expelled as preadults (Behnke & 
Parish, 1979b: Cypess. Lucia. Dunsford & Enriquez. 
1988). 
There is little argument that the tissue larval stages 
of Hplygyrus provide essential stimuli for the 
expression of host-protective immunity (Van Zandt. 
1961; Jacobson, Brooks & Cypess, 1982) although the 
relative contribution of L3 and L4 stages growing in 
vim in the normal site of development has not been 
evaluated. Moreover, this is complicated by the 
opposing effect of adult worm immunomodulation 
which not only prevents host immunity affecting adult 
worm survival (Jacobson rt al.. 1982; Robinson. 
Behnke & Williams, 1988) but also downregulates 
acquired immunity elicited by juvenile stages (Behnke. 
Hannah & Pritchard, 1983; Cayzer & Dobson, 1983; 
Enriquez, Cypess & Wassom, 1988; Pritchard & 
Behnke, 1985). This has been clearly demonstrated in 
experiments where infections terminated before the 
adult phase of infection were shown to generate 
considerably more potent immunity than those in 
which the infection was allowed to progress to patency 
(Behnke &, Robinson, 1985; Kerboeuf & Jolivet, 
1984). 
Although protective immunity is most effectively 
acquired when exposure is limited to tissue larvae, the 
exact stages of H.po1ygyz.a responsible for stimuli 
eliciting acquired immunity still remain to be eluci- 
dated. Following on from our earlier work, the studies 
of Enriquez, Cypess & Wassom (1988) and the recent 
work of Larrick, Semprevivo. Maloney & Tritschler 
(1991). we report here that infections terminated 
during the L4 stage provide by far the most 
immunogenic signals, but unexpectedly L3 larvae are 
also shown to be capable of eliciting potent host- 
protective immunity by themselves. 
MATERIALS AND METHODS 
Mice. The mice used in this study were purchased from 
Harlan Olac Ltd or were bred in the departmental animal 
house. All animals were housed under conventional animal 
house conditions with access to food and water crdlihi~um. 
Paru.~itc~. The parasite used in this work was originally 
obtained in 1975 from the Wellcome Research Laboratories 
(Beckenham, Kent) since when it has been passaged regularly 
in CFLP mice. Our strain corresponds to H.polygyrus hukerr 
as reported by Durette-Desset, Kinsella & Forrester (1972) 
and Behnke, Keymer & Lewis (1991). The methods used for 
maintenance and infection have been reported previously 
(Jenkins & Behnke. 1977). Adult parasites were recovered by 
a 6 h incubation, at 37°C of small intestines suspended m a 
gauze, in 50 ml beakers containing Hanks’s saline as 
described by Jenkins & Behnke (1977). Larval stages of the 
parasite were recovered by separate digestion of intestinal 
tissues from individual mice in a mixture of pepsin, 
hydrochloric acid (5 g pepsin (BDH), 5 ml cont. HCI and 500 
mldistilled water), in conical flasks maintained in a watcrbath 
at 37°C for I.5 h. Following incubation the contents were 
poured through a stainless steel mesh (size 38 llrn. Endecott 
Sieves) held in a separating funnel. The funnel was then 
rinsed with PBS five times into a beaker and the fluid 
containing worms was transferred to a IO cm Petri dish for 
counting under a dissecting microscope. 
Mmsurement of n’orms. Worms were fixed m 2.59,;) 
formalin and were drawn to scale using a camera lucida 
arrangement attached to a microscope. The drawings were 
then measured using a digitizer pad and an IBM computer 
with a program for conversion of lengths traced into discrete 
units (courtesy of Dr R. Ramsey). A maximum of 20 females 
were measured from the pooled worms from each 
experimental group. When the total recovery was lower all 
available female worms were measured. 
Prepurcr~ion of anrigms. Outbred CFLP mice were infected 
with 400 L3 of H.po/y~~~trs and were killed 6 or 14 days later 
to provide L4 and adult worms, respectively. L4 stages wcrc 
isolated by gently scraping off the mucosa and then 
incubating anterior sections of the small intestine in Hanks’s 
saline at 37°C in gauze bags held over small glass beakers. 
Adult worms were isolated by opening the small intestine and 
incubating tissues with gut contents in the same manner. 
When sufficient numbers of worms had collected, the 
parasites were washed IO times in ice cold sterile PBS and 
were homogenized in a minimal volume of PBS using a glass 
tissue homogenizer held in an ice bath. The resulting 
suspension was centrifuged at 30.0001: for I h at 4°C to 
remove coarse particulate matter. The supernatant was 
filtered (0.22 pm filter. Millipore). analysed for protein 
concentration using a method modified from Lowry. 
Rosenborough, Farr & Randall (I 951). aliquoted and stored 
at -40°C. 
Anthelminfic~. lvermectin (IV) was available as a 
commercial preparation (Ivomec) whtch contained 1% w.v 
of the anthelmintic (MSD, AGVET). A dose of 20 mg kg 
was obtained by appropriate dilution in distilled water and 
the resulting fine suspension was injected in a volume of 0.2 
0.3 ml within minutes of preparation (Wahid. Behnke & 
Conway, 1989). Pyrantel embonate (Strongid-P paste. Pfizer) 
was administered orally to some mice in experiments 7 and IO 
at a dose of 100 mg kg ‘, which is known to be adequate for 
removing all adult worms from the intestinal lumen (Behnke 
& Wakelin. 1977). 
,Meusurenw~l of antdmi~ rtqxmws. Specific anti-worm 
antibodies were measured by a standard ELISA. BrieIIy. 
ELISA microtitre plates were coated with 50 ,nI of w~orm 
antigen (5 mg ml ‘). Alkaline phosphatase conjugated sheep- 
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A. Expt.2. 
“r Treatment 12 h p.i. “r 
B. Expt.3. 
Treatment 24 h p.i. 
lirLl irch ~llli 
24 48 72 24 48 72 24 48 72 
Hours after treatment with ivermectin 
FIG. 2. Experiments 2-6. Growth of female H.polyg_~~~~ during the j-day period following treatment 
with ivermectin. Experimental details as in legend to Fig. I. Closed bars represent control. untreated 
groups. Open bars represent groups treated with ivermectin at the times shown. When available 20 
female worms were measured at each time point. 
anti-mouse IgG (whole molecule, Sigma) or IgGl (Serotec) 
were used to measure total or subclass specific responses. 
After addition of the substrate (P-nitrophenylphosphatase) 
colour changes were read at 410 nm on a Dynatech MR700 
Microplate Reader. Sera were assayed individually after 
storage at ~ 40°C. Each plate included control hyperimmune 
serum (HIM) which was raised as described by Behnke & 
Parish (1979b) and naive serum and these were used to 
calculate the relative response index (RRI). Sera were 
assayed in triplicate and the mean optical density (O.D.) for 
individual sera was expressed as a percentage of the O.D. 
obtained with the hyperimmune reference serum. after 
subtraction of the value for naive control serum from each 
value. RRIs measured on individual sera on different 
occasions showed little variation and the results were 
consistently reproducible. The same stocks of aliquoted HIM 
and control naive serum were used throughout the study. The 
spectrum of antigens recognized by antibodies in the sera of 
infected mice was examined by the Western blotting tech- 
nique essentially as described by Carr & Pritchard (1987). 
PBS-soluble adult worm antigen was electrophoretically 
transferred to nitrocellulose membranes (Schleicher & Scuell) 
following separation on 5-20% gradient SDS-PAGE. Strips 
of membrane were blocked with 5% skimmed milk in PBS- 
Tween 20 (0.05%) and then incubated overnight at 4°C with 
appropriate test sera (I: 100) using 5% skimmed milk in PBS- 
Tween 20. After washing in PBS-Tween 30 the strips were 
Incubated with “‘I-sheep anti-mouse polyvalent immuno- 
globulins (18.5 kBq;‘strip, Amersham) for 2 h at room 
temperature. Following washing in PBS-Tween 20 (3 x 20 
min) the strips were air dried. fixed to the interior of an X-ray 
cassette and exposed to an X-ray film (Fuji) at ~ 80°C in the 
presence of an intensifying screen. The molecular weights 
were estimated with reference to the migration of standard 
molecular weight markers. 
S/urixfiwl analy.sis o/ rr.w/~.c. The results are presented as 
group mean values * standard error (s E 21 ). Non-parametric 
statistical procedures were used to analyse the data sets. 
because of small sample sires (Sokal & Rohlf, 1969). When 
more than two groups required comparison at a single time 
point the Kruskal-Wallis statistic H was calculated to 
determine whether there was a significant treatment effect. II 
significant, specific groups were compared to the control 
group (or as stated) by the Mann-Whitney c’ test. Correla- 
tions between variables were tested by the Spearman Rank 
Correlation Test and the statistic r.) is given, as appropriate. 
Probabilities were calculated from statistics tables and arc 
presented as follows: *P = 0.05: **0.05 > P 2 0.02: ***0.02 
> P > 0.01: ****0.01 > P > 0.001; *****p < 0.001. _
RESULTS 
The ejfcct of‘ivrrmectin (IV) on tissue residmt .xtugc.y c!f 
Heligmosomoides polygyrus 
A prerequisite for the main objective of this project 
was certainty that IV would kill or at least prevent 
Acquired immunity to H. polygyrus 703 
-.- Expt. 7 
* Expt. 8 
- Expt. 9 
20 - 
I 
0 2 4 6 8 10 12 
Duration of primary infection in days 
FIG. 3. Experiments 7-9. Acquired immunity to Heligmoso- 
moidespolygyrus, elicited by primary infections ranging from 
12 h to 10 days in duration, in female NlH mice. Details are 
given in Table 1. 
further development of worms, within hours of treat- 
ment, otherwise we could not be certain that elicited 
immunity would be attributable to stimuli from para- 
site stages resident in host tissues prior to or at the time 
of treatment. Therefore, it was essential to assess the 
speed of larvicidal activity of IV after injection, a feature 
not examined in earlier studies (Wahid et al., 1989). 
The results of six experiments, each examining a 
different period of exposure, are illustrated in Fig. I. It 
is evident that in all cases stable worm populations 
were recovered from control mice over the 3-day 
period of observation. Furthermore, the numbers of 
worms recovered in relation to the inocula admin- 
istered show that recovery by pepsin digestion was 
efficient and that few worms were missed. Additional, 
infected but not treated, control groups were killed 3 
weeks after each infection and the worms were isolated 
by the standard Baerman procedure at a time when all 
the worms could be accurately recovered. These 
control groups yielded 162, 182, 214, I55 and 199 
worms in Experiments 2-6, respectively, thereby con- 
firming that the recovery of worms in the early stages 
of infection by the digestion technique was accurate 
and efficient. 
By comparison with control groups relatively few 
worms were recovered from mice treated with IV. 
When IV was given 12 h after infection the reduction in 
worm recovery 24 h later (i.e. 1.5 days after infection) 
was 71.2%. By 48 hit was 87.5% and by 72 h, 99.5%. 
When older infections were treated the yield of 
parasites was greater. For example when the 6-day 
infection was treated (Fig. 1 F, Experiment 6 144h), the 
reduction 24 h later was only 19.7%. 
However, it is evident that while worms in control 
mice continued developing normally in each case, 
those in IV-treated mice showed no further growth as 
adjudged by their size 2472 h after treatment (Fig. 2). 
Furthermore careful examination of these specimens 
showed that in no case did worms from mice treated 
with IV 12, 24 or 48 h after infection moult to the L4 
stage (Fig. 2A-C) and none treated 72 and 144 h p.i. 
developed into juvenile worms. In all cases the mean 
length of worms from control groups was longer than 
from IV-treated groups 24 h after administration of 
the drug. 
One further control was used to confirm that worms 
in animals treated with IV died rapidly after treatment. 
In Experiment 6 in which the reduction of worm 
burden 24 h after treatment was relatively small, 
additional groups of mice were treated as follows. The 
intestine was scraped gently and the tissues were then 
incubated without enzyme in a standard Baerman 
procedure. The recovery of worms from control mice 
treated in this way 24,48 and 72 h after treatment with 
saline was 118, 183 and 186. Mice dosed with IV 
yielded 41, I4 and three worms showing that the 
parasites in treated mice were far less mobile, since this 
recovery technique depends on the parasites migrating 
out of the tissues. After incubation the tissues were 
digested in enzyme and the yields were as follows, 
control mice 65, 44 and 41, respectively (indicating 
that the majority had migrated out earlier), whilst 
those of treated mice were 105, 125 and 128 (indicating 
that the majority has stayed in situ). 
Acquired immunity elicited during infections of varying 
duration, abbreviated during the tissue phase of 
development 
Four experiments, in which ivermectin was 
administered to groups of mice at varying time points 
following infection, were carried out to determine the 
minimal period of infection required to elicit acquired 
immunity. Experiments 7-10 involved female NIH 
mice, a primary infection with 250 larvae, followed by 
ivermectin treatment of relevant groups, a period of 
rest to allow ivermectin to be metabolized and elim- 
inated by the host, followed by a challenge infection. 
The exact protocol for each experiment, together with 
details of minor variations in detail between the 
experiments and the statistical analysis, are presented 
in Table 1. For greater ease of interpretation the data 
from Experiments 7-9 are also expressed in terms of 
percentage protection in Fig. 3. 
In Experiment 7 ivermectin was given 48 and 96 h 
and 6, 8 and 10 days after infection. Acquired 
immunity exceeded 95% in all cases with the weakest 
(96. I %) in the group treated 48 h after exposure. The 
second experiment in this series (Experiment 8) 
examined earlier periods of treatment. Again 
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TABLE ~-ACQUIRED ~MMUNKY TO Heli~mosomoide.~ polygw~~ STIMULATED BY PRMARY IN~ECT~NS OP VARYING DI~RA~ 1oh 
Primary 
infection: 
No 
No II 
No I/ 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Treatment 
hours (h) or 
days (d) after Experiment 
infection5 7 
None 135 ziz 5.6 (5) 
IOd 143.4* 17.1 (5) 
6d 
12h 
24 h 
36 h 
**** 
48 h 5.2 + 2.3 (6) 
60 h 
72 h 
84 h 
Yes 06 h 0 (5)**** 
Yes 
Yes 
Yes 
6d 
Xd 
IOd 
**** 
0 (6) 
**** 
0.2 * 0.2 (6) 
*XI** 
0.5 f 0.3 (6) 
Yes’ 35 d 
**** 
58.2* 20.8 (6) 
- 
- 
Number of worms recovered f s E M (n)t 
- 
Experiment 
8 
- 
90.7+ 2.6 (7) 
**** 
38.3 f 15.5 (6) 
61.9& 13.7(7)** 
**** 
34.3 zk 14.5 (6) 
**** 
51.8f13.7(5) 
**** 
I.O*O.6(6) 
**** 
0.8hO.5 (6) 
Experiment 
9 
Experiment 
IO 
98.4h4.2 (5) 79.0 f 3.2 (6) 
94.0f 10.0 (6) 
69.6f 16.0 (14) 
27.3* 15.3 (II;* 
35.9+ 
23.3 f 
**** 
12.0 (8) 
**** 
13.7 (8) 
**** 
1.0&0.9 (8) 
**** 
O(l2) 
**** 
31.7+11.7(7) 
**** 
12.9+7.5(14) 
**** 
6.9&5.2(10) 
**** 
6. I f 6.0 (IO) 
**** 
0.2zIzO.2 (6) 
0 (6)**** 
t The mice in Experiments 7-9 were female NIH, those in Experiment 10 were female SWR. Challenge infections comprised 
150 L3 (Experiment 7), 100 L3 (Experiments 8 and 9) or 120 L3 (Experiment 10) and were given 38,34.35 and 35 days after the 
primary infection, respectively. 
1 The primary infection consisted of 250 L3 in each experiment. Additional groups of mice were killed on day 21 aftcl 
primary infection to monitor the level of establishment and the numbers of worms recovered were as follows: Experiment 7. 
242.5& 16.4 (n=4); Experiment 8,214.7*8.7 (n=3); Experiment 9, 171.0+9.5 (n=4) and Experiment 10, 178.0*3.4(~=4). 
5 Groups of mice were treated at the hours or days shown after primary infection. In each case additional groups of two to 
three mice (not shown), infected with the primary infection and then treated at the times shown. were killed on day 21 p.i. to 
confirm the efficacy of ivermectin. Of 62 mice examined across the four experiments only one mouse in Experiment 8 (treated 
with ivermectin 48 h after infection) carried 126 worms. The remaining mice were all without worms. 
11 Control groups for persistence of ivermectin. 
7 These two groups were not treated with ivermectin but were given pyrantel a few days (Experiment 7. day 35: Experiment 
9, day 33) before challenge to eliminate adult worms. 
Stutistical analysis ~7fresuits 
Experiment 7, H = 39.442 (P i 0.001); Experiment 8, H = 29.070 (P < 0.001); Experiment 9, H = 43.196 (P > 0.0001); 
Experiment 10. H = 25.259 (P = 0.00012). 
Additional comparisons were made using the Mann-Whitney U test and control groups (no primary infection and no 
anthelmintic treatment) in each case. 
**0.05 P P 2 0.025. 
****0.01 > P 2 0.001. 
Acquired immunity to H. polygyus 705 
treatment with ivermectin after 72 h of infection 
generated solid resistance to challenge. Earlier treat- 
ment produced acquired immunity but variable in 
degree ranging among individual mice from 0 to 
100%. Groups treated 12, 24, 36 and 48 h after 
infection had variable worm burdens following chal- 
lenge with curiously fewer worms in the groups treated 
12 and 36 h compared with those treated 24 and 48 h 
after infection, respectively. However, in each case 
there was a significant reduction in worms relative to 
controls and we attribute the lack of a consistent 
pattern to small sample sizes at a time when events are 
delicately poised vis-ri-vis appropriate stimulation for 
acquired immunity. Because of this variation in the 
12248 h period, a third experiment was carried out in 
which larger sample sizes were employed particularly 
in groups treated 12 and 24 h after infection (Experi- 
ment 9). This time treatment 12 h after infection did 
not generate significant protection from challenge but 
treatment at 24 h gave a 72% reduction in worm 
burden and comparable reduction in groups treated 60 
and 72 h after exposure. Overall it can be seen from 
these data that infections terminated up to 60 h post- 
infection (p.i.) were surprisingly effective at eliciting 
acquired immunity in NIH mice, despite some vari- 
ation among groups and between experiments. In 
contrast all mice treated with IV after 60 h p.i. showed 
> 95% protection. 
*,lrrth experiment along the same lines was 
ceiled out in SWR mice which expel worms from the 
fifth week of a primary infection (Table I, Experiment 
IO). Accordingly the period to challenge was reduced 
to 4 weeks on this occasion, to ensure that comparisons 
could be made before the control mice also began to 
reject parasites. In this case a 12 h period of exposure 
was sufficient to elicit 83.7% protection to challenge. 
IgG and IgCl serum antibody responses to infection 
Antibody responses were measured in Experiment 9 
using adult worm homogenate antigen in ELISA and 
the results are presented in Fig. 4. Sera taken at 
autopsy, 5 weeks after challenge, were also analysed 
for responses to L4 antigens and these results are given 
in Fig. 5. It is evident that the longer the infection was 
allowed to progress the more intense an antibody 
response was elicited. Following challenge the differ- 
ences between the groups were further exaggerated in 
both total IgG and IgGl subclass antibody. More- 
over, there was an almost perfect correlation between 
the intensity of the IgG 1 antibody response to L4 and 
adult worm antigens and the percentage protection at 
autopsy 5 weeks after challenge infection. 
Recognition of parasite antigens 
The pattern of recognition of antigens was studied 
using the Western blotting technique (data not 
shown). Four antigens, 123, 62, 46 and 34 kDa were 
strongly recognized by the control hyperimmune 
serum. None were seen by control naive serum. Sera 
from mice exposed to abbreviated infections followed 
by challenge recognized all four antigens, although the 
intensity of recognition varied. In general sera from 
mice exposed to longer periods of primary exposure 
exhibited stronger recognition of these antigens. 
Challenge control sera recognized only the 123 and 34 
kDa antigens. 
An additional three antigens of approximate mo- 
lecular weight 16, 18 and 20 kDa were recognized by 
sera from the experimental groups, particularly by 
mice from group H which had been exposed to a 6-day 
immunizing infection and showed solid resistance to 
challenge. These three bands were weakly recognized 
by control hyperimmune serum and there was also 
weak reactivity in the challenge control group. 
DISCUSSION 
Although H.polygyrus is considerably more resist- 
ant to ivermectin than other parasitic nematodes, 
doses of IO-20 mg kg-’ are totally effective in 
eradicating the worms (Wahid et al., 1989). However, 
before using IV to abbreviate infections at crucial 
stages of larval development, it was necessary to 
determine precisely how rapidly the drug exerted its 
effect on parasites, an aspect not considered in earlier 
publications. Our data (Fig. 1) show that the recovery 
of early developmental stages is reduced by over 70% 
in the 24 h period following treatment. The remaining 
worms recovered by digestion may have been alive at 
autopsy, but measurements showed that there was no 
growth and development after treatment (Fig. 2) and 
we are therefore confident that mice treated 1248 h 
after infection did not experience L4 stages at all. 
Treatment at 72 and 144 h resulted in a greater 
proportion of the worm burden being recovered by 
digestion. These L4 were considerably larger than the 
earlier stages but again did not grow from the time of 
treatment (Fig. 2D,E) and were considered to be 
immobilized and/or dead. Their slower loss was likely 
attributed to a greater size and the associated diffi- 
culties in their complete removal from the muscularis 
externa by the host response, rather than to resistance 
to IV. We conclude that ivermectin at the dose 
employed immobilized the worms rapidly, within 24 h, 
enabling their destruction by a local inflammatory and 
granulomatous reaction and consequently all the 
antigenic components of these stages were made 
available to the host’s immune system. 
Previous attempts to induce immunity to H. poly- 
gyrus using infective larvae have had mixed fortunes. 
Vaccination with dead exsheathed larvae given by 
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****0.01 > P 2 0.001. 
intravenous (Ey, 1988a), intraperitoneal, intra- 
muscular or subcutaneous (Chaicumpa et al., 1977) 
injection failed to elicit resistance. Likewise sub- 
cutaneous injection of live ensheathed larvae (Lueker, 
Rubin & Andersen. 1968) or an extract of ensheathed 
larvae (Van Zandt, 1962) proved ineffectual. In 
contrast potent immunity was elicited by vast doses 
(4000) of live exsheathed larvae given subcutaneously 
(and therefore into an abnormal tissue site where 
development would have been transient, Lueker et ul., 
1968; Rubin, Lueker, Flom & Andersen, 1971) and, 
although this protocol was refined later with 
smaller doses being equally effective in outbred mice 
(Hosier, Sackman & Idell, 1974), protection in inbred 
C57BL and AKR mice never exceeded 30% (Lueker & 
Hepler, 1975). Acquired immunity was also induced 
successfully by intravenous injection of live L3 larvae. 
a proportion of which succeeded in migrating to the 
mucosa and developed normally. Anthelmintic 
treatment was given IO days after the last of one to 
three injections, allowing in the latter cases some adult 
worms temporary residence before challenge. After 
one such inoculation protection was < 50%. 
However, more recently Larrick et ul. (1991) showed 
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FIG. 5. Experiment 9. IgG and IgGl antibody responses to L4 larvae of Heligmoso- 
modes polygyrus 5 weeks after challenge infection and the relationship between the 
intensity of antibody activity and protective immunity. Groups as in Fig. 4. Statistical 
andysis qfresults: IgG response in week 5, H = 38.8579 (P < 0.0001). IgGl response 
in week 5, H = 41.4152 (P < 0.0001). Additional comparisons were made using 
the Mann-Whitney U test and group A as the comparative group in all cases. The 
key to symbols used is as follows: **0.05 > P L 0.025; ****O.Ol > P 2 0.001. 
Intensity of the IgG response vs percentage protection in week 5: TS = 0.7857 
(P = 0.0543). Intensity of the IgGl response vs percentage protection in week 5: 
rs = 0.9643 (P = 0.0182). 
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that subcutaneous injections of L3 (isolated on day 2) 
and L4 induced acquired immunity to H.pofygyrus in 
BALB/c mice. Our results confirm and extend their 
findings, showing for the first time that L3 stages in situ 
in the intestinal mucosa provide key antigenic stimuli 
for acquired resistance in responder mouse strains. 
During the first 12-24 h period of infection, mice 
would have experienced little else apart from the 
invasive L3 stages, in the mucosa and submucosa 
(Sukhdeo et al., 1984). The worms do not reach the 
muscularis externu until l-3 days after infection and 
the moult to the L4 occurs 90-94 h pi., although signs 
of development of L4 features become apparent from 
60 h (Bryant, 1973). Clearly, on the basis of our results, 
these early invasive stages are potently immunogenic 
even during the first 36 h period of infection. 
It is perhaps pertinent that mice vaccinated with L3 
larvae developed intense antibody responses to a 
common somatic antigen of L3 and adult worms and 
to cuticular antigens of invasive larvae but did not 
show anti-L3-ES antibody activity (Ey, l988a), and 
whilst we did not test sera for anti-L3-ES activity, it is 
probable that our immunizing protocol was superior 
in this respect. Indeed immunization with repeated 
doses of L3-ES products eventually induced detectable 
resistance to challenge, but overall percentage 
protection was still poorer than in our experiments 
with 24 h periods of exposure to infection (Ey, 1988a). 
Furthermore, whereas vaccination with live 2-day p.i. 
L3 generated 60% protection (Larrick et al., 1991) 
our SJL mice showed 83.7 and 91.2% protection when 
primary exposure was restricted by IV treatment 12 
and 24 h after infection, respectively. Exsheathed 
larvae secrete essentially a single dominant molecule of 
23 kDa during the first 10 h of culture and in relatively 
small amounts (to.2 ng per larva per day). It is not 
until later that additional factors appear in ES 
products (Ey, 1988b). If the same holds true for worms 
in viva, this 23 kDa antigen is likely to be the source of 
host-protective immunity. All the other L3 antigens 
were presumably made available to mice when dead 
larvae were used without success in immunization (Ey. 
1988a). 
The strongest resistance to challenge was acquired 
when primary infections were terminated 46 days 
after infection at a time corresponding almost exactly 
to the L4 phase of infection, the preadult moult 
occurring 144166 h p.i. (Bryant, 1973). We are 
therefore in total agreement with Larrick et al. 
(1991) that L4 stages of H.polygyrus are potently 
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immunogenic, but on the basis of our experiments we 
cannot separate the contribution of L4 stages from 
that provided by the earlier L3. Larrick et ai. (1991) 
showed that L4 stages of H.po~y~yr~s induce pro- 
tective immunity in isolation from L3 stages, although 
their experimental procedure involved subcutaneous 
rather than mucosal presentation of the antigens. 
Taken altogether. our studies establish that both larval 
stages release highly immunogenic antigens which 
elicit potent acquired immunity. This extraordinary 
immunogenicity of larval stages has to be contrasted 
with the prolonged survival of adult worms on 
primary exposure when patent infections last for more 
than 20 weeks in NIH mice (Robinson et a/., 1989). 
Although immunizing infections in which larvae were 
allowed to progress to the patent adult stage were only 
briefly considered here (Experiments 7 and 9) it is 
evident from these that once adult worms developed, 
acquired immunity was significantly weakened 
confirming earlier reports (Behnke & Robinson. 1985; 
Dobson, Sitepu & Brindley, 1985; Enriquez, Cypess & 
Wassom, 1988; Kerboeuf & Jolivet, 1984). The 
immunodepressive properties of adult parasites are 
believed to inhibit the acquisition of acquired resist- 
ance (Behnke et cd., 1983; Pritchard & Behnke. 1985) 
and exposure, limited to larval stages free from this 
influence, generated potent acquired resistance. 
The greater resistance of mice experiencing a &day 
immunization was associated with a more intense 
antibody response to L4 and adult worm antigens 
(both IgG and IgGl). Indeed there was an almost 
perfect correlation between the intensity of the IgGl 
antibody response and the percentage protection 5 
weeks after challenge infection, supporting the role of 
IgGl antibodies in mediating resistance to 
H.polygyrus (see Pritchard, Williams, Behnke & Lee, 
1983; Williams & Behnke, 1983). The intensity of the 
antibody response to adult worm antigens was 
surprising since the mice would not have experienced 
antigens unique to adult worms during the priming 
infections. A significantly more intense secondary 
response to adult worms was reported by Jacobson et 
al. (1982), but these authors used a I&day priming 
infection, during which mice would have experienced 
adult worm antigens. Several antigens in homogenates 
of adult and larval stages share identical molecular 
weights (e.g. molecule(s) at 65 kDa) suggesting that 
there may be common epitopes on the different 
development stages of the worm (Pritchard, Maizels, 
Behnke & Appleby, 1984; Pritchard & Carr, 1987). 
However, stage-specific antigens have also been 
recognized (Adams, Monroy. East & Dobson, 1987: 
Adams, East, Monroy, Washington & Dobson. 1987) 
including a 16 kDa molecule on the cuticular surface 
of L4 (Pritchard ef al., 1984). In the present study mice 
would have been sensitized only to L3 and L4 antigens 
depending on the duration of the priming infection 
and indeed, 2 weeks after exposure as well as on the 
day of challenge, groups experiencing a 12 and 24 h 
immunizing infection had antibody titres only 
marginally higher than naive mice. Then depending on 
the intensity of the secondary response, adult stages 
would have been experienced transiently and it was at 
this stage that anti-adult worm antibody titrcs rose 
significantly above control groups (Fig. 4). 
The strong recognition of low molecular weight 
adult worm antigens may be particularly significant. 
Antigens of 17. 18 and 20 kDa were imlllunoprecip- 
itated by purified IgGl from hyperimmune sera. 
demonstrably effective in passive transfer (Pritchard (‘I 
al., 1983). In the present study these antigens were also 
recognized by the control hyperimmune serum. as 
expected. but there was considerably more reactivity 
in scra from mice sensitized by 4 ~6 day abbreviated 
infections, despite the fact that their overall reactivity 
against adult worm homogenate was less intense than 
that of HIM. Thus exposure to L4 stages, which 
possess antigens wzith comparable molecular weights 
although not necessarily the same molecules 
(Pritchard et al., 1984) led to preferential stimulation 
of a response against these antigens, indicating that 
some arc indeed likely to be identical or possess 
common epitopcs (Pritchard & Carr. 1987). 
Monroy. Dobson & Adams (1989) have suggested 
that the low molecular weight antigens ( < 20 kDa) of 
adult worms represent the elusive immunomodulatory 
factors (IMF) of the parasite. However, if adult and 
L4 stages share low molecular weight factors, the 
potent immunogenic~ty of the larval stages in com- 
parison to the relatively poor immunogenicity ofadult 
worms (Jacobson rt cd., 1982) poses an intriguing 
paradox. One explanation may be that larval 
immunogens enter the circulation eliciting immunity 
whilst their IMFs keep cellular effecters at bay, 
protecting the larvae locally in their sites of 
development. In support of the latter hypothesis. 6- 
day old L4 stages have been found to secrete < 14 kDa 
IMF (Losson, Lloyd & Soulsby. 1985). Furthermore. 
larval IMFs may explain the resilience of tissue stages 
in the inflammed intestines of sensitized mice where 
development is slowed (Ey, 1988a) and despite the 
vigorous granulomatous reactions around them 
(Jones & Rubin, 1974). many worms survive to return 
to the gut lumen as stunted preadults (Ey. 1988a) from 
which the majority are lost soon after arrival. Perhaps 
experience of dying L4 stages and their IMFs enables 
the host to resist larval and adult worm immunomod- 
ulation on secondary cxposurc, facilitating a 
s~i~cicntly intcnsc local inflammatory rcsponsc to 
damage the worms before their evasive strategies 
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become fully effective, with consequent slower growth 
and loss from the gut lumen on completion of 
development. 
Finally, our experiments have demonstrated 
unequivocally that the early developmental stage of 
H.pol_vgyrus, the parasitic L3, provides important 
stimuli for acquired resistance in responder strains of 
mice. Acquired resistance was enhanced when mice 
also experienced L4 stages and therefore protective 
immunity to H.polygyrus may be evoked by responses 
to antigen sets from both L3 and L4 stages. The crucial 
issues to tackle next will be to confirm the identi- 
fication of the L3 antigens involved (vis-&vis Ey’s 23 
kDa antigen) and to determine whether the expression 
of acquired immunity in mice which have experienced 
only L3 stages is mediated by similar effector 
mechanisms to those known to act against L4 and 
preadult parasites or whether a novel combination is 
involved. 
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